BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol 2014; 20(32): 11033-11053 [PMID: 25170193 DOI: 10.3748/wjg.v20.i32.11033]
URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11033.htm
Number Citing Articles
1
Salwa M. Abo El‐khair, Hatem A. El‐Alfy, Ayman Z. Elsamanoudy, Dina Elhammady, Nahed Abd‐elfattah, Bassem Eldeek, Khaled Farid. Development of a novel glycated protein‐based fibrosis prediction score for determination of significant liver fibrosis in HCV‐infected patients, a preliminary studyJournal of Medical Virology 2020; 92(12): 3525 doi: 10.1002/jmv.26204
2
Andrea Dalbeni, Simone Romano, Michele Bevilacqua, Anna Piccoli, Egidio Imbalzano, Anna Mantovani, Marco Benati, Martina Montagnana, Angela Donato, Gioia Torin, Cinzia Monaco, Filippo Cattazzo, Angela Tagetti, Veronica Paon, Donatella Ieluzzi, Laura Iogna Prat, Davide Roccarina, Flavio Ribichini, Franco Capra, Pietro Minuz, Cristiano Fava. Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low‐moderate liver fibrosisJournal of Viral Hepatitis 2020; 27(11): 1214 doi: 10.1111/jvh.13355
3
Ming-Sian Wu, Chun-Hsiang Wang, Fan-Chen Tseng, Hsuan-Ju Yang, Yin-Chiu Lo, Yi-Ping Kuo, De-Jiun Tsai, Wan-Ting Tsai, Guann-Yi Yu. Interleukin-17F expression is elevated in hepatitis C patients with fibrosis and hepatocellular carcinomaInfectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0152-7
4
Salvo Danilo Lombardo, Sebastiano Lombardo. Some stability results for a model of Hepatitis C including alanine aminotransferase and immune systemInternational Journal of Biomathematics 2020; 13(08): 2050080 doi: 10.1142/S1793524520500801
5
Daniel Sepulveda-Crespo, Salvador Resino, Isidoro Martinez. Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver FibrosisDrugs 2021; 81(4): 419 doi: 10.1007/s40265-020-01458-x
6
Silvia Goñi Esarte, Regina Juanbeltz, José Manuel Zozaya, Juan Isidro Úriz, Jesús Castilla, José Ignacio Herrero. Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agentsGastroenterología y Hepatología (English Edition) 2020; 43(5): 248 doi: 10.1016/j.gastre.2019.03.027
7
Wanvisa Udomsinprasert, Jiraphun Jittikoon, Sorraya Sukkho, Nicha Pojarassangkul, Sermsiri Sangroongruangsri, Usa Chaikledkaew. Decreased circulating vitamin D reflects adverse outcomes of hepatitis C virus infection: A systematic review and meta-analysisJournal of Infection 2020; 81(4): 585 doi: 10.1016/j.jinf.2020.06.025
8
Ashwin Rammohan. Current management & future directions in post-liver transplant recurrence of viral hepatitisJournal of Liver Transplantation 2021; 3: 100027 doi: 10.1016/j.liver.2021.100027
9
Rong Wu, Shu Dong, Fei-Fei Cai, Xiao-Le Chen, Meng-Die Yang, Ping Liu, Shi-Bing Su. Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic AnalysisMolecules 2019; 24(2): 338 doi: 10.3390/molecules24020338
10
Melania Gaggini, Fabrizia Carli, Chiara Rosso, Ramy Younes, Romina D’Aurizio, Elisabetta Bugianesi, Amalia Gastaldelli. Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver DiseaseInternational Journal of Molecular Sciences 2019; 20(24): 6333 doi: 10.3390/ijms20246333
11
Jonas D. Stief, Moritz Haase, Lutz Lüdemann, Dorothea Theilig, Moritz Schmelzle, Bernd Hamm, Timm Denecke, Dominik Geisel. Combined morphological and functional liver MRI using spin-lattice relaxation in the rotating frame (T1ρ) in conjunction with Gadoxetic Acid-enhanced MRIScientific Reports 2019; 9(1) doi: 10.1038/s41598-018-37689-y
12
Ricardo Diaz-Aragon, Michael C. Coard, Sriram Amirneni, Lanuza Faccioli, Nils Haep, Michelle R. Malizio, Takashi Motomura, Zehra N. Kocas-Kilicarslan, Alina Ostrowska, Rodrigo M. Florentino, Carla Frau. Therapeutic Potential of HNF4α in End-stage Liver DiseaseOrganogenesis 2021; 17(3-4): 126 doi: 10.1080/15476278.2021.1994273
13
Mariam Mgeladze, George Kamkamidze. LONG-TERM HEALTH OUTCOME AMONG HCV PATIENTS WITH ADVANCED LIVER FIBROSIS TREATED THROUGH HCV ELIMINATION PROGRAM IN GEORGIAPARIPEX INDIAN JOURNAL OF RESEARCH 2021; : 144 doi: 10.36106/paripex/1611361
14
Jan Korbecki, Iwona Szatkowska, Patrycja Kupnicka, Wojciech Żwierełło, Katarzyna Barczak, Iwona Poziomkowska-Gęsicka, Jerzy Wójcik, Dariusz Chlubek, Irena Baranowska-Bosiacka. The Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Oral Cavity and Abdominal OrgansInternational Journal of Molecular Sciences 2022; 23(13): 7151 doi: 10.3390/ijms23137151
15
Takashi Taniguchi, Yoshihide Asano, Kouki Nakamura, Takashi Yamashita, Ryosuke Saigusa, Yohei Ichimura, Takehiro Takahashi, Tetsuo Toyama, Ayumi Yoshizaki, Shinichi Sato. Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic SclerosisThe Journal of Rheumatology 2017; 44(8): 1198 doi: 10.3899/jrheum.161092
16
Paul G. Carty, Michael McCarthy, Sinéad M. O’Neill, Cillian F. De Gascun, Patricia Harrington, Michelle O’Neill, Susan M. Smith, Conor Teljeur, Mairin Ryan. Laboratory‐based testing for hepatitis C infection using dried blood spot samples: A systematic review and meta‐analysis of diagnostic accuracyReviews in Medical Virology 2022; 32(4) doi: 10.1002/rmv.2320
17
Janice Taylor, Sian Carr-Lopez, Amy Robinson, Robert Malmstrom, Karsten Duncan, Archana Maniar, A.C. Del Re, Jannet M. Carmichael. Determinants of Treatment Eligibility in Veterans With Hepatitis C Viral InfectionClinical Therapeutics 2017; 39(1): 130 doi: 10.1016/j.clinthera.2016.11.019
18
Zubia Jamil, Sharmin Arif, Anum Khan, Asghar Aurangzeb Durrani, Nayyar Yaqoob. Vitamin D Deficiency and Its Relationship with Child-Pugh Class in Patients with Chronic Liver DiseaseJournal of Clinical and Translational Hepatology 2018; 6(2): 1 doi: 10.14218/JCTH.2017.00055
19
Sherin Zakaria , Alaa E. El-Sisi. Daclatasvir and Sofosbuvir Mitigate Hepatic Fibrosis Through Downregulation of TNF-α / NF-κB Signaling PathwayCurrent Molecular Pharmacology 2020; 13(4): 318 doi: 10.2174/1874467213666200116114919
20
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad. Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infectionWorld Journal of Hepatology 2017; 9(36): 1305-1314 doi: 10.4254/wjh.v9.i36.1305
21
Elane Reyes-Avilés, Lenche Kostadinova, Anne Rusterholtz, Angelica Cruz-Lebrón, Yngve Falck-Ytter, Donald D. Anthony, Naglaa H. Shoukry. Presence of Rheumatoid Factor during Chronic HCV Infection Is Associated with Expansion of Mature Activated Memory B-Cells that Are Hypo-Responsive to B-Cell Receptor Stimulation and Persist during the Early Stage of IFN Free TherapyPLOS ONE 2015; 10(12): e0144629 doi: 10.1371/journal.pone.0144629
22
Batbold Batsaikhan, Ming-Ying Lu, Ming-Lun Yeh, Ching-I Huang, Chung-Feng Huang, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Ping-Hsin Hsieh, Wan-Long Chuang, Jin-Ching Lee, Ming-Lung Yu, Chia-Yen Dai. Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis CJournal of the Chinese Medical Association 2019; 82(4): 277 doi: 10.1097/JCMA.0000000000000064
23
Haina Xie, Dongyu Xie, Jingxian Zhang, Wenye Jin, Yue Li, Jun Yao, Zhiqiang Pan, Donghao Xie. ROS/NF-κB Signaling Pathway-Mediated Transcriptional Activation of TRIM37 Promotes HBV-Associated Hepatic FibrosisMolecular Therapy - Nucleic Acids 2020; 22: 114 doi: 10.1016/j.omtn.2020.08.014
24
Luigi Elio Adinolf, Ira Jacobson, Mark Bondin, Patrice Cacoub. Expert Opinion on Managing Chronic HCV Infection in Patients with Type 2 Diabetes MellitusAntiviral Therapy 2018; 23(1_suppl): 11 doi: 10.3851/IMP3255
25
Amir Hossein Babaei, Ali Reza Safarpour, Mohammad Reza Fattahi, Vida Ahmadi. Epidemiology of Hepatitis C Virus Infection Among 1,959 Patients in Shiraz, Southern Iran, Between 1991 and 2016Archives of Clinical Infectious Diseases 2020; 15(1) doi: 10.5812/archcid.98849
26
Yi-Wen Huang, Albert Qin, Chan-Yen Tsai, Pei-Jer Chen. Novel Pegylated Interferon for the Treatment of Chronic Viral HepatitisViruses 2022; 14(6): 1128 doi: 10.3390/v14061128
27
Aisha Elsharkawy, Reham Samir, Mohamed El-Kassas. Fibrosis regression following hepatitis C antiviral therapyWorld Journal of Hepatology 2022; 14(6): 1120-1130 doi: 10.4254/wjh.v14.i6.1120
28
H. Imai, H. Kamei, Y. Onishi, Y. Ishizu, M. Ishigami, H. Goto, Y. Ogura. Diagnostic Usefulness of APRI and FIB-4 for the Prediction of Liver Fibrosis After Liver Transplantation in Patients Infected with Hepatitis C VirusTransplantation Proceedings 2018; 50(5): 1431 doi: 10.1016/j.transproceed.2018.03.005
29
Abdellah Akil, Mark Endsley, Saravanabalaji Shanmugam, Omar Saldarriaga, Anoma Somasunderam, Heidi Spratt, Heather L. Stevenson, Netanya S. Utay, Monique Ferguson, MinKyung Yi. Fibrogenic Gene Expression in Hepatic Stellate Cells Induced by HCV and HIV Replication in a Three Cell Co-Culture Model SystemScientific Reports 2019; 9(1) doi: 10.1038/s41598-018-37071-y
30
Alaa E. El-Sisi, Sherin Zakaria. Potential Anti-Fibrotic Effect of Direct Acting Antiviral Drugs on CCl4 Induced Hepatic Fibrosis in RatsEgyptian Journal of Basic and Clinical Pharmacology 2019; 9 doi: 10.32527/2019/101414
31
Rowan Ahmed, Roaa Kareem, Nanditha Venkatesan, Rinky A Botleroo, Opemipo D Ogeyingbo, Renu Bhandari, Mallika Gyawali, Abeer O Elshaikh. Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus InfectionCureus 2021;  doi: 10.7759/cureus.17237
32
Seung Kak Shin, Jin-Woo Lee, Hannah Ra, Oh Sang Kwon, Jong-Beom Shin, Young-Joo Jin, Sangheun Lee, Ki Jun Han, Young Nam Kim, Tae Hun Kim, Yun Soo Kim, Ju Hyun Kim. Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter StudyJournal of Korean Medical Science 2019; 34(41) doi: 10.3346/jkms.2019.34.e264
33
Alia S Dadabhai, Behnam Saberi, Katie Lobner, Russell T Shinohara, Gerard E Mullin. Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials dataWorld Journal of Hepatology 2017; 9(5): 278-287 doi: 10.4254/wjh.v9.i5.278
34
Flavia F Fernandes, Juliana Piedade, Livia Guimaraes, Estevao P Nunes, Ursula Chaves, Rafaela V Goldenzon, Sandra W Cardoso, Joana Duarte, Beatriz Grinsztejn, Valdilea G Veloso, Gustavo Pereira, Hugo Perazzo. Effectiveness of direct‐acting agents for hepatitis C and liver stiffness changing after sustained virological responseJournal of Gastroenterology and Hepatology 2019; 34(12): 2187 doi: 10.1111/jgh.14707
35
Yu-long Bao, Li Wang, Hai-ting Pan, Tai-ran Zhang, Ya-hong Chen, Shan-jing Xu, Xin-li Mao, Shao-wei Li. Animal and Organoid Models of Liver FibrosisFrontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.666138
36
Hoda El Aggan, Nahla Farahat, Nevine El Deeb, Ahmed Zeid, Assem El-Shendidi. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injuryMicrobial Pathogenesis 2019; 131: 65 doi: 10.1016/j.micpath.2019.03.032
37
Amira Isaac, Khaled Hamdy Abd El-Mageed, Hany Haroun Kaisar, Hany Samir Rasmy, Ramy Samir Abd Elhamid Ghait, Ibrahim Magdy Ibrahim, George Safwat Riad. Assessment of serum Resistin in detecting Insulin Resistance and their impact on response to direct acting antiviral in chronic viral hepatitis C patientsEgyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00136-1
38
Marta Cilla, Emmanuel A. Tsochatzis. Elastography of the Liver and Beyond2021; : 27 doi: 10.1007/978-3-030-74132-7_3
39
Yangwenshu Liu, Qin Kuang, Xianling Dai, Minxia Zhan, Li Zhou, Liancai Zhu, Bochu Wang. Deficiency in Inactive Rhomboid Protein2 (iRhom2) Alleviates Alcoholic Liver Fibrosis by Suppressing Inflammation and Oxidative StressInternational Journal of Molecular Sciences 2022; 23(14): 7701 doi: 10.3390/ijms23147701
40
Sara Sweidan, Shaker El-Sappagh, Hazem El-Bakry, Sahar Sabbeh, Farid A. Badria, Kyung-Sup Kwak. A Fibrosis Diagnosis Clinical Decision Support System Using Fuzzy KnowledgeArabian Journal for Science and Engineering 2019; 44(4): 3781 doi: 10.1007/s13369-018-3670-8
41
John F. Dillon, Michael H. Miller, Emma M. Robinson, Adrian Hapca, Mohsen Rezaeihemami, Christopher Weatherburn, Paul G. McIntyre, Bill Bartlett, Peter T. Donnan, Kathleen A. Boyd, Ellie Dow. Intelligent liver function testing (iLFT): A trial of automated diagnosis and staging of liver disease in primary careJournal of Hepatology 2019; 71(4): 699 doi: 10.1016/j.jhep.2019.05.033
42
Gordana Avramovic, Maeve Reilly, Walter Cullen, Juan Macías, Geoff McCombe, Tina McHugh, Cristiana Oprea, Alistair Story, Julian Surey, Caroline Sabin, Sandra Bivegete, Peter Vickerman, Josephine Walker, Zoe Ward, John S Lambert. HEPCARE EUROPE- A case study of a service innovation project aiming at improving the elimination of HCV in vulnerable populations in four European citiesInternational Journal of Infectious Diseases 2020; 101: 374 doi: 10.1016/j.ijid.2020.09.1445
43
Isabel Conde, Carmen Vinaixa, Marina Berenguer. Cirrosis por hepatitis C. Estado actualMedicina Clínica 2017; 148(2): 78 doi: 10.1016/j.medcli.2016.09.019
44
Bertille Elodie E. Edinga, Jean Joel Bigna, Jobert Richie Nansseu, Adrienne Y. Tchapmi, Stéphane Fargeon M. Mbouna, Suzanne Belinga, Oudou Njoya, Vicky Jocelyne Ama-Moor, Richard Njouom. Simple noninvasive tests for liver fibrosis diagnosis in sub-Saharan African adults with chronic viral hepatitis B or C: A cross sectional study in CameroonClinica Chimica Acta 2022; 536: 56 doi: 10.1016/j.cca.2022.09.009
45
Moutaz Derbala, Mohammed Elshiekh Elbadri, Aliaa Mohamed Amer, Saad AlKaabi, Khaleel Hassan Sultan, Yasser Medhat Kamel, Eman Hassan Satti Elsayed, Tony Yervant Avades, Prem Chandra, Fatma M Shebl. Aspartate transaminase to platelet ratio index in hepatitis C virus and <italic>Schistosomiasis</italic> coinfectionWorld Journal of Gastroenterology 2015; 21(46): 13132-13139 doi: 10.3748/wjg.v21.i46.13132
46
Janet Lin, Cammeo Mauntel-Medici, Anjana Bairavi Maheswaran, Sara Baghikar, Oksana Pugach, Ellen M Stein, Michelle T Martin, Hai Nguyen. Factors predicting staging and treatment initiation for patients with chronic hepatitis C infection: insurance a key predictorJournal of Public Health 2022; 44(1): 148 doi: 10.1093/pubmed/fdaa276
47
I. V. Maev, E. I. Kuznetsova, D. N. Andreev, D. T. Dicheva. Diagnostic accuracy of predictive indexes of liver fibrosis in patients with chronic hepatitis CTerapevticheskii arkhiv 2020; 92(2): 24 doi: 10.26442/00403660.2020.02.000261
48
Beshoy Yanny, Sammy Saab, Francisco Durazo, Nyan Latt, Amanda Mitry, Mira Moris Mikhail, Ramy M. Hanna, Antony Aziz, Amandeep Sahota. Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mLDigestive Diseases and Sciences 2018; 63(12): 3480 doi: 10.1007/s10620-018-5283-1
49
Florin Mihai, Anca Trifan, Carol Stanciu, Ana Maria Singeap, Bogdan Cucuteanu, Corina Lupascu Ursulescu, Corina Pop, Irina Girleanu, Tudor Cuciureanu, Dragos Negru, Camelia Cojocariu. Liver Remodeling on CT Examination in Patients with HCV Compensated Cirrhosis Who Achieved Sustained Virological Response after Direct-Acting Antivirals TreatmentMedicina 2020; 56(4): 171 doi: 10.3390/medicina56040171
50
Jose Ramón Vidal-Castiñeira, Antonio López-Vázquez, Paula Diaz-Bulnes, Susana Díaz-Coto, Leonardo Márquez-Kisinousky, Jesús Martínez-Borra, Carmen A. Navascues, Paloma Sanz-Cameno, Juan de la Vega, Aurora Astudillo, Manuel Rodríguez, Carlos López-Larrea. Genetic contribution of endoplasmic reticulum aminopeptidase 1 polymorphisms to liver fibrosis progression in patients with HCV infectionJournal of Molecular Medicine 2020; 98(9): 1245 doi: 10.1007/s00109-020-01948-1
51
Léonie Petitclerc, Giada Sebastiani, Guillaume Gilbert, Guy Cloutier, An Tang. Liver fibrosis: Review of current imaging and MRI quantification techniquesJournal of Magnetic Resonance Imaging 2017; 45(5): 1276 doi: 10.1002/jmri.25550
52
OV Churbakova, VG Akimkin, VV Pavlov, DV Pechkurov. Epidemiological Situation of Chronic Hepatitis C Virus Infection in Russia and the Samara RegionЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT 2020; : 72 doi: 10.35627/2219-5238/2020-332-11-72-77
53
Pamela Valva, Daniela A R&iacute;os, Elena De Matteo, Maria V Preciado. Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damageWorld Journal of Gastroenterology 2016; 22(4): 1367-1381 doi: 10.3748/wjg.v22.i4.1367
54
Natália Borges Nunes Gomes, Ulysses S. Torres, Maria Lucia Cardoso Gomes Ferraz, Giuseppe D'Ippolito. Autoimmune hepatitis in practice, from diagnosis to complications: What is the role of imaging? A clinicoradiological reviewClinical Imaging 2021; 74: 31 doi: 10.1016/j.clinimag.2020.12.032
55
Adauto CASTELO, Carlos Eduardo BRANDÃO MELLO, Rosangela TEIXEIRA, Jose Valdez Ramalho MADRUGA, Tania REUTER, Leila Maria Moreira Beltrão PEREIRA, Giovanni Faria SILVA, Mario Reis ÁLVARES-DA-SILVA, Heverton ZAMBRINI, Paulo Roberto Abrão FERREIRA. HEPATITIS C IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM: BURDEN OF DISEASEArquivos de Gastroenterologia 2018; 55(4): 329 doi: 10.1590/s0004-2803.201800000-74
56
Justin Chan, Neliswa Gogela, Hui Zheng, Sara Lammert, Tokunbo Ajayi, Zachary Fricker, Arthur Y. Kim, Gregory K. Robbins, Raymond T. Chung. Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatmentDigestive Diseases and Sciences 2018; 63(2): 486 doi: 10.1007/s10620-017-4749-x
57
Roberto Catanzaro, Morena Sciuto, Cristina Lanzafame, Baskar Balakrishnan, Francesco Marotta. Platelet to lymphocyte ratio as a predictive biomarker of liver fibrosis (on elastography) in patients with hepatitis C virus (HCV)-related liver diseaseIndian Journal of Gastroenterology 2020; 39(3): 253 doi: 10.1007/s12664-020-01038-7
58
Bassem Matta, Tzu-Hao Lee, Keyur Patel. Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIVCurrent HIV/AIDS Reports 2016; 13(5): 279 doi: 10.1007/s11904-016-0329-5
59
Sanghyeok Lim, Seung Hyun Kim, Yongsoo Kim, Young Seo Cho, Tae Yeob Kim, Woo Kyoung Jeong, Joo Hyun Sohn. Coefficient of Variance as Quality Criterion for Evaluation of Advanced Hepatic Fibrosis Using 2D Shear-Wave ElastographyJournal of Ultrasound in Medicine 2018; 37(2): 355 doi: 10.1002/jum.14341
60
Vaia Valiakou, Petros Eliadis, Eirini Karamichali, Ourania Tsitsilonis, John Koskinas, Urania Georgopoulou, Pelagia Foka. Differential Expression of the Host Lipid Regulators ANGPTL-3 and ANGPTL-4 in HCV Infection and TreatmentInternational Journal of Molecular Sciences 2021; 22(15): 7961 doi: 10.3390/ijms22157961
61
Melissa Borgia, Michele Dal Bo, Giuseppe Toffoli. Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular CarcinomaCancers 2021; 13(17): 4387 doi: 10.3390/cancers13174387
62
Shu Dong, Fei-fei Cai, Qi-long Chen, Ya-nan Song, Yang Sun, Bin Wei, Xiao-yan Li, Yi-yang Hu, Ping Liu, Shi-bing Su. Chinese herbal formula Fuzheng Huayu alleviates CCl4-induced liver fibrosis in rats: a transcriptomic and proteomic analysisActa Pharmacologica Sinica 2018; 39(6): 930 doi: 10.1038/aps.2017.150
63
Cheng-Han Lee, Yung-Liang Wan, Tse-Hwa Hsu, Shiu-Feng Huang, Ming-Chin Yu, Wei-Chen Lee, Po-Hsiang Tsui, Yi-Cheng Chen, Chun-Yen Lin, Dar-In Tai. Interpretation US Elastography in Chronic Hepatitis B with or without Anti-HBV TherapyApplied Sciences 2017; 7(11): 1164 doi: 10.3390/app7111164
64
KofoO Soyebi, AjibolaS Agboola, GaniyatK Oyeleke. Diagnostic value of ultrasonographic portal venous index in the assessment of liver fibrosis in chronic viral hepatitis in Lagos, NigeriaJournal of Radiation Medicine in the Tropics 2021; 2(2): 72 doi: 10.4103/jrmt.jrmt_14_21
65
Bokyeong Ryu, Kyung-Yeon Eo, Ja-Jun Jang, C-Yoon Kim, Ji Min Lee, Hanseul Oh, Ukjin Kim, Jin Kim, Hyun-Ho Lee, Young-Mok Jung, Jae-Hak Park. A case of active incomplete biliary cirrhosis in an aged female Japanese macaque (Macaca fuscata )Journal of Medical Primatology 2018; 47(4): 270 doi: 10.1111/jmp.12347
66
Sreelakshmi Kotha, ShuetFong Neong, Keyur Patel. Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinomaExpert Review of Molecular Diagnostics 2018; 18(8): 713 doi: 10.1080/14737159.2018.1496020
67
Iman Jamhiri, Khashayar Shahin, Zahra Khodabandeh, Kurosh Kalantar, Jamal Sarvari, Amir Atapour, Fatemeh Mina, Asma Ahmadnejad, Seyed Younes Hosseini. Recombinant NS3 Protein Induced Expression of Immune Modulatory Elements in Hepatic Stellate Cells During Its Fibrotic ActivityViral Immunology 2018; 31(8): 575 doi: 10.1089/vim.2018.0018
68
Tao Huang, Yuan-Qing-Xiao Li, Ming-Yu Zhou, Rui-Han Hu, Gao-Liang Zou, Jian-Chao Li, Shu Feng, Yong-Mei Liu, Chang-Qin Xin, Xue-Ke Zhao. Focal adhesion kinase-related non-kinase ameliorates liver fibrosis by inhibiting aerobic glycolysis <i>via </i>the FAK/Ras/c-myc/ENO1 pathwayWorld Journal of Gastroenterology 2022; 28(1): 123-139 doi: 10.3748/wjg.v28.i1.123
69
E. Teran-Hinojosa, H. Sobral, C. Sánchez-Pérez, A. Pérez-García, N. Alemán-García, J. Hernández-Ruiz. Differentiation of fibrotic liver tissue using laser-induced breakdown spectroscopyBiomedical Optics Express 2017; 8(8): 3816 doi: 10.1364/BOE.8.003816
70
Yingying Zhao, Huichun Xing, Xiaomei Wang, Weini Ou, Hong Zhao, Ben Li, Yue Li, Ying Duan, Liwei Zhuang, Wei Li, Danying Cheng, Min Quan, Yu Zhang, Shibo Ji. Management of Diabetes Mellitus in Patients with Chronic Liver DiseasesJournal of Diabetes Research 2019; 2019: 1 doi: 10.1155/2019/6430486
71
Isabel Conde, Carmen Vinaixa, Marina Berenguer. Hepatitis C-related cirrhosis. Current statusMedicina Clínica (English Edition) 2017; 148(2): 78 doi: 10.1016/j.medcle.2016.09.035
72
Paul G. Carty, Conor Teljeur, Cillian F. De Gascun, Paddy Gillespie, Patricia Harrington, Aiden McCormick, Michelle O’Neill, Susan M. Smith, Mairin Ryan. Another Step Toward Hepatitis C Elimination: An Economic Evaluation of an Irish National Birth Cohort Testing ProgramValue in Health 2022;  doi: 10.1016/j.jval.2022.05.010
73
Erica Silberstein, Laura Ulitzky, Livia Alves Lima, Nicoleta Cehan, Andréa Teixeira-Carvalho, Philippe Roingeard, Deborah R. Taylor, Ratna B. Ray. HCV-Mediated Apoptosis of Hepatocytes in Culture and Viral PathogenesisPLOS ONE 2016; 11(6): e0155708 doi: 10.1371/journal.pone.0155708
74
Zeyuan Song, Tao Wu, Jinpeng Sun, Haoran Wang, Feng Hua, Yap San Min Nicolas, Rupesh KC, Kun Chen, Zhen Jin, Jun Liu, Mingshun Zhang. Metformin attenuates post‐epidural fibrosis by inhibiting the TGF‐β1/Smad3 and HMGB1/TLR4 signaling pathwaysJournal of Cellular and Molecular Medicine 2021; 25(7): 3272 doi: 10.1111/jcmm.16398
75
G. Eser Karlidag, O. Arslan Solmaz. Are adropin, apelin, elabela, asprosin and betatrophin biomarkers for chronic hepatitis and staging of fibrosis?Biotechnic & Histochemistry 2020; 95(2): 152 doi: 10.1080/10520295.2020.1714732
76
Oleksandra Ya. Pryshliak, Larysa Ye. Kovalchuk, Oleksandra V. Marynchak, Oleksandr P. Boichuk, Ihor H. Hryzhak, Oksana Ye. Kondryn, Valentyna F. Piuryk. FUNCTIONAL STATE OF NEUTROPHIC GRANULOCYTES’ GENOME OF THE PERIPHERAL BLOOD IN PATIENTS WITH CHRONIC HEPATITIS C WITH CONCOMITANT DIABETES MELLITUS TYPE IIWiadomości Lekarskie 2020; 73(8): 1671 doi: 10.36740/WLek202008116
77
Pawel E. Ferdek, Daria Krzysztofik, Kinga B. Stopa, Agnieszka A. Kusiak, Milena Paw, Dawid Wnuk, Monika A. Jakubowska. When healing turns into killing – the pathophysiology of pancreatic and hepatic fibrosisThe Journal of Physiology 2022; 600(11): 2579 doi: 10.1113/JP281135
78
Sunil Taneja, Sunil Tohra, Ajay Duseja, Radha Krishan Dhiman, Yogesh Kumar Chawla. Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C—An Experience from a Tertiary Care HospitalJournal of Clinical and Experimental Hepatology 2016; 6(4): 282 doi: 10.1016/j.jceh.2016.08.001
79
Yoko Idobe-Fujii, Ryoko Omoso, Shinya Fujii, Hiromitsu Fujiwara, Yuki Nakamura, Takahiro Nomi, Yuichiro Sasaki, Hiroyuki Sasaki, Hajime Isomoto, Yoshikazu Murawaki. Normal values of combinational elastography in adult liver: the influence of ageJournal of Medical Ultrasonics 2021; 48(2): 207 doi: 10.1007/s10396-021-01082-6
80
Moema S. Santana, Rute Lopes, Isabela H. Peron, Carla R. Cruz, Ana M.M. Gaspar, Paulo I. Costa. Natural Bioactive Compounds as Adjuvant Therapy for Hepatitis C InfectionCurrent Nutrition & Food Science 2021; 17(5): 458 doi: 10.2174/1573401316999201009152726
81
Saeed M. El-Nahaas, Normeen Hany Rady, Shimaa Malek, Khaled Serag. Changes in serum interferon-γ-inducible protein-10 levels and liver stiffness among chronic hepatitis C Egyptian patients in response to directly acting antiviral agentsEuropean Journal of Gastroenterology & Hepatology 2021; 33(1S): e335 doi: 10.1097/MEG.0000000000002059
82
Qi Yao, Ying Wang, Zhiyu Dong, Chencen Lai, Botao Chang, Qiuju Gong, Shuaijun Ren, Dongxue Sun, Jie Lu, Ying Gao. Dichondra repens J.R.Forst. and G.Forst.: A Review of Its Traditional Uses, Chemistry, Pharmacology, Toxicology and ApplicationsFrontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.608199
83
A. Ferreira-Gonzalez. Diagnostic Molecular Pathology2017; : 485 doi: 10.1016/B978-0-12-800886-7.00038-8
84
Sadhna B. Nandwana, Josephine Finazzo, Lauren F. Alexander, Kelly Cox. Using qualitative descriptors of chronic liver disease on MRI: A practice prone to errorClinical Imaging 2021; 74: 89 doi: 10.1016/j.clinimag.2020.12.023
85
Yu-Hsiang Hsieh, Danielle Signer, Anuj V. Patel, Valentina Viertel, Mustapha Saheed, Risha Irvin, Mark S. Sulkowski, David L. Thomas, Richard E. Rothman. Advanced liver fibrosis and care continuum in emergency department patients with chronic hepatitis CThe American Journal of Emergency Medicine 2019; 37(2): 286 doi: 10.1016/j.ajem.2018.08.067
86
Andrei A. Bunaciu, Hassan Y. Aboul-Enein, Vu Dang Hoang. Vibrational Spectroscopy Applications in Biomedical, Pharmaceutical and Food Sciences2020; : 39 doi: 10.1016/B978-0-12-818827-9.00004-4
87
Bashar M Attar, David H Van Thiel. Hepatitis C virus: A time for decisions. Who should be treated and when?World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(1): 33-40 doi: 10.4292/wjgpt.v7.i1.33
88
Mousumi Khatun, Ratna B. Ray. Mechanisms Underlying Hepatitis C Virus-Associated Hepatic FibrosisCells 2019; 8(10): 1249 doi: 10.3390/cells8101249
89
Kumeshini Sukalingam, Kumar Ganesan, Baojun Xu. Protective Effect of Aqueous Extract from the Leaves of Justicia tranquebariesis against Thioacetamide-Induced Oxidative Stress and Hepatic Fibrosis in RatsAntioxidants 2018; 7(7): 78 doi: 10.3390/antiox7070078
90
I. A. Karabak, D. Yu. Lobzin, V. E. Karev. Clinical and immunomorphological predictors of the adverse course of chronic hepatitis CJournal Infectology 2020; 12(2): 79 doi: 10.22625/2072-6732-2020-12-2-79-87
91
Fuu-Jen Tsai, Pei-Yuu Yang, Chao-Jung Chen, Ju-Pi Li, Te-Mao Li, Jian-Shiun Chiou, Chi-Fung Cheng, Po-Heng Chuang, Ting-Hsu Lin, Chiu-Chu Liao, Shao-Mei Huang, Bo Ban, Wen-Miin Liang, Ying-Ju Lin. Decreased overall mortality rate with Chinese herbal medicine usage in patients with decompensated liver cirrhosis in TaiwanBMC Complementary Medicine and Therapies 2020; 20(1) doi: 10.1186/s12906-020-03010-6
92
Kayla L. Frost, Solène Marie, Nathan J. Cherrington. Mechanistic basis of increased susceptibility to nephrotoxicants in chronic liver diseaseCurrent Opinion in Toxicology 2022; 31: 100347 doi: 10.1016/j.cotox.2022.100347
93
Silvia Goñi Esarte, Regina Juanbeltz, José Manuel Zozaya, Juan Isidro Úriz, Jesús Castilla, José Ignacio Herrero. Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agentsGastroenterología y Hepatología 2020; 43(5): 248 doi: 10.1016/j.gastrohep.2019.03.017
94
Jacqueto Zephyr, Desaboini Nageswara Rao, Sang V. Vo, Mina Henes, Klajdi Kosovrasti, Ashley N. Matthew, Adam K. Hedger, Jennifer Timm, Elise T. Chan, Akbar Ali, Nese Kurt Yilmaz, Celia A. Schiffer. Deciphering the Molecular Mechanism of HCV Protease Inhibitor Fluorination as a General Approach to Avoid Drug ResistanceJournal of Molecular Biology 2022; 434(9): 167503 doi: 10.1016/j.jmb.2022.167503
95
Chao-Yu Chen, Ting-Yao Wang, Wei-Ming Chen, Kai-Hua Chen, Yao-Hsu Yang, Pau-Chung Chen, Vincent Chin-Hung Chen. Bilateral oophorectomy and the risk of hepatocellular carcinoma in women with hepatitis C: A population-based studyMaturitas 2021; 146: 11 doi: 10.1016/j.maturitas.2020.12.006
96
Yahang Wang, Yuanyuan Li, Hua zhang, Leilei Zhu, Jie Zhong, Jiakai Zeng, Cong Meng, Jiasheng Wu, Tianming Wang, Rong Shi, Weian Yuan, Jian Jiang, Ping Liu, Yueming Ma. Pharmacokinetics-based comprehensive strategy to identify multiple effective components in Huangqi decoction against liver fibrosisPhytomedicine 2021; 84: 153513 doi: 10.1016/j.phymed.2021.153513
97
Andrew D. Smith, Cody R. Branch, Kevin Zand, Charu Subramony, Haowei Zhang, Katherine Thaggard, Richard Hosch, Jason Bryan, Amit Vasanji, Michael Griswold, Xu Zhang. Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of CirrhosisRadiology 2016; 280(3): 771 doi: 10.1148/radiol.2016151542
98
Joseph R. Coyle, Emily Goerge, Kathryn Kacynski, Ruby Rodgers, Patricia Raines, Linda S. Vail, Sugandha Lowhim. Hepatitis C Virus Infections Associated with Unsafe Injection Practices at a Pain Management Clinic, Michigan, 2014–2015Pain Medicine 2016; : pnw157 doi: 10.1093/pm/pnw157
99
Paul Kennedy, Mathilde Wagner, Laurent Castéra, Cheng William Hong, Curtis L. Johnson, Claude B. Sirlin, Bachir Taouli. Quantitative Elastography Methods in Liver Disease: Current Evidence and Future DirectionsRadiology 2018; 286(3): 738 doi: 10.1148/radiol.2018170601
100
Shen Pan, Xiao-Qi Wang, Qi-Yong Guo. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imagingWorld Journal of Gastroenterology 2018; 24(18): 2024-2035 doi: 10.3748/wjg.v24.i18.2024
101
Linshi Wu, Weiqing Qiu, Jianhua Sun, Jian Wang. SENP1 attenuates the liver fibrosis through down-regulating the expression of SMAD2Biochemical and Biophysical Research Communications 2018; 495(1): 755 doi: 10.1016/j.bbrc.2017.11.047
102
Yuan Zhou, Rong Wu, Fei-Fei Cai, Wen-Jun Zhou, Yi-Yu Lu, Hui Zhang, Qi-Long Chen, Shi-Bing Su. Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysisJournal of Ethnopharmacology 2021; 264: 113021 doi: 10.1016/j.jep.2020.113021
103
Johnathan D. Guest, Brian G. Pierce. Structure-Based and Rational Design of a Hepatitis C Virus VaccineViruses 2021; 13(5): 837 doi: 10.3390/v13050837
104
Jing Guo, Ingolf Sack, Stephan Rodrigo Marticorena Garcia. Liver Elastography2020; : 69 doi: 10.1007/978-3-030-40542-7_6
105
Cristina Vassalle, Salvatore Petta, Alessia Pepe, Antonio Craxi, Mark Bondin, Patrice Cacoub. Expert Opinion on Managing Chronic HCV in Patients with Cardiovascular DiseaseAntiviral Therapy 2018; 23(1_suppl): 35 doi: 10.3851/IMP3248
106
Wilhelm Salzberger, Gloria Martrus, Kai Bachmann, Hanna Goebels, Leonard Heß, Martina Koch, Annika Langeneckert, Sebastian Lunemann, Karl J. Oldhafer, Caroline Pfeifer, Tobias Poch, Laura Richert, Christoph Schramm, Ramez Wahib, Madeleine J. Bunders, Marcus Altfeld, Jorge Bernardino de la Serna. Tissue-resident NK cells differ in their expression profile of the nutrient transporters Glut1, CD98 and CD71PLOS ONE 2018; 13(7): e0201170 doi: 10.1371/journal.pone.0201170
107
James C. Connolly, Joseph K. Lim. Non-invasive Fibrosis Assessment of Patients with Hepatitis C: Application of Society Guidelines to Clinical PracticeCurrent Hepatology Reports 2019; 18(2): 249 doi: 10.1007/s11901-019-00471-3
108
Akito Nozaki, Makoto Chuma, Koji Hara, Satoshi Moriya, Hiroyuki Fukuda, Kazushi Numata, Katsuaki Tanaka, Manabu Morimoto, Kentaro Sakamaki, Takeharu Yamanaka, Masaaki Kondo, Shin Maeda. Sofosbuvir-based therapies associated with regression of liver fibrosis in patients with hepatitis C virus infectionMedicine 2021; 100(12): e25110 doi: 10.1097/MD.0000000000025110
109
Dong Ho Lee, Jae Young Lee, Byung Ihn Choi. Elastography - Applications in Clinical Medicine2022;  doi: 10.5772/intechopen.102853
110
Pablo M. Santoro, Alejandra Sandoval-Bórquez, Alejandro H. Corvalan. Non-Coding RNAs2020;  doi: 10.5772/intechopen.88895
111
Mingyang Li, Hui Zhuang, Lai Wei. How would China achieve WHO’s target of eliminating HCV by 2030?Expert Review of Anti-infective Therapy 2019; 17(10): 763 doi: 10.1080/14787210.2019.1675509
112
Hongliang Li, Xuanbin Wang, Ying Liu, Dongfeng Pan, Ye Wang, Nian Yang, Longchao Xiang, Xiaojun Cai, Yibin Feng. Hepatoprotection and hepatotoxicity of Heshouwu , a Chinese medicinal herb: Context of the paradoxical effectFood and Chemical Toxicology 2017; 108: 407 doi: 10.1016/j.fct.2016.07.035
113
Sadhna Dhingra, Juhi D. Mahadik, Yaman Tarabishy, Sarah B. May, John M. Vierling. Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitisPathology 2022; 54(6): 686 doi: 10.1016/j.pathol.2022.01.009
114
Chongyang Ma, Mengpei Zhao, Yuqiong Du, Shuang Jin, Xiaoyi Wu, Haiyan Zou, Qiuyun Zhang, Lianyin Gao, Chih-Yuan Ko. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Qingdu Decoction against Chronic Liver InjuryEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/6661667
115
Camila Guerra Marangon, Jóice Teixeira de Bitencorte, Rafael Tomoya Michita, Vagner Ricardo Lunge, Deivid Cruz dos Santos, Mário Reis Álvares-da-Silva, Daniel Simon. Association between MICA rs2596542 Polymorphism with the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C PatientsPathology & Oncology Research 2020; 26(3): 1519 doi: 10.1007/s12253-019-00738-6
116
Shigemasa Takamizawa, Toru Yamada, Koichi Kitamura, Eiji Hiraoka. Difficulty of acute hepatitis C diagnosis in a hospitalised patientBMJ Case Reports 2018; 11(1): e226907 doi: 10.1136/bcr-2018-226907
117
Mohamed Salama, Manal Nomir, Maryan Fahmi, Amal El-Gayar, Mamdouh El-Shishtawy. Potential Role of Microfibrillar-Associated Protein 4, Fibrotic Indices and Oxidative Stress in Hepatocellular CarcinomaScientia Pharmaceutica 2018; 86(4): 44 doi: 10.3390/scipharm86040044
118
Léonie Petitclerc, Guillaume Gilbert, Bich N. Nguyen, An Tang. Liver Fibrosis Quantification by Magnetic Resonance ImagingTopics in Magnetic Resonance Imaging 2017; 26(6): 229 doi: 10.1097/RMR.0000000000000149
119
Ahmed Algazeery, Ahmed H. Moustafa, Ashraf S. El-Sayed, Marwa G. Rizk, Norhan A. Sabbah. Evaluation of the Curative and Protective Role of Fresh Chicory Juice in Treatment of Hepatic Fibrosis in Male Albino RatsBiomedical and Pharmacology Journal 2021; 14(3): 1331 doi: 10.13005/bpj/2234
120
CARINA S. LIBRELOTTO, ANA PAULA DE SOUZA, MÁRIO R. ÁLVARES-DA-SILVA, DANIEL SIMON, RAFAEL R. DIHL. Evaluation of the genetic toxicity of sofosbuvir and simeprevir with and without ribavirin in a human-derived liver cell lineAnais da Academia Brasileira de Ciências 2021; 93(4) doi: 10.1590/0001-3765202120200632
121
Federico Sáez-Royuela, Pedro Linares, Luis A. Cervera, Carolina Almohalla, Francisco Jorquera, Sara Lorenzo, Isidro García, Guillermo Karpman, Ester Badia, María A. Vallecillo, Adriana Moncada, Sara Calvo, José L. Olcoz. Evaluation of advanced fibrosis measured by transient elastography after hepatitis C virus protease inhibitor-based triple therapyEuropean Journal of Gastroenterology & Hepatology 2016; 28(3): 305 doi: 10.1097/MEG.0000000000000533
122
Yang Zheng, Jiahui Wang, Jiaru Wang, Haiyuan Xie, Tiejian Zhao. Effect of Curcumol on the Fenestrae of Liver Sinusoidal Endothelial Cells Based on NF-κB Signaling PathwayEvidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/8590638
123
Johnasha D Stuart, Eduardo Salinas, Arash Grakoui. Immune system control of hepatitis C virus infectionCurrent Opinion in Virology 2021; 46: 36 doi: 10.1016/j.coviro.2020.10.002
124
Maria Guido. Practical Hepatic Pathology: a Diagnostic Approach2018; : 233 doi: 10.1016/B978-0-323-42873-6.00016-0
125
Navneet Kaur, Gitanjali Goyal, Ravinder Garg, Chaitanya Tapasvi, Sonia Chawla, Rajneet Kaur. Potential role of noninvasive biomarkers during liver fibrosisWorld Journal of Hepatology 2021; 13(12): 1919-1935 doi: 10.4254/wjh.v13.i12.1919
126
Nicoletta Ciccarelli, Massimiliano Fabbiani, Anna C. Brita, Ramona De Marco, Pierfrancesco Grima, Roberta Gagliardini, Alberto Borghetti, Roberto Cauda, Simona Di Giambenedetto. Liver fibrosis is associated with cognitive impairment in people living with HIVInfection 2019; 47(4): 589 doi: 10.1007/s15010-019-01284-8
127
Hemda Schmilovitz-Weiss, Rachel Gingold-Belfer, Alon Grossman, Nidal Issa, Doron Boltin, Yichayaou Beloosesky, Nira Morag Koren, Joseph Meyerovitch, Avraham Weiss, Mark W. Sonderup. Lowering the upper limit of serum alanine aminotransferase levels may reveal significant liver disease in the elderlyPLOS ONE 2019; 14(4): e0212737 doi: 10.1371/journal.pone.0212737
128
Jingga Morry, Worapol Ngamcherdtrakul, Wassana Yantasee. Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticlesRedox Biology 2017; 11: 240 doi: 10.1016/j.redox.2016.12.011
129
Sang Hoon Ahn, Won Hyeok Choe, Yoon Jun Kim, Jeong Heo, Dorota Latarska-Smuga, Jiho Kang, Seung Woon Paik. Impact of Interferon-Based Treatment on Quality of Life and Work-Related Productivity of Korean Patients with Chronic Hepatitis CGut and Liver 2020; 14(3): 368 doi: 10.5009/gnl18100
130
Mohamed S. Mohamed, Amr S. Hanafy, Mohamed A.A. Bassiony, Samia Hussein. Sofosbuvir and daclatasvir plus ribavirin treatment improve liver function parameters and clinical outcomes in Egyptian chronic hepatitis C patientsEuropean Journal of Gastroenterology & Hepatology 2017; 29(12): 1368 doi: 10.1097/MEG.0000000000000963
131
Chang Fan, Fu Rong Wu, Jia Fu Zhang, Hui Jiang. A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver FibrosisEvidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/4780383
132
Ming‐Lung Yu, Wei‐Lun Tsai, Chi‐Jen Chu, Jia‐Horng Kao. Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study The Kaohsiung Journal of Medical Sciences 2021; 37(3): 245 doi: 10.1002/kjm2.12317
133
Daphne Hahn, Caroline S. Stokes, Ralf Kaiser, Markus R. Meyer, Frank Lammert, Frank Gruenhage. Antidepressant effects of direct-acting antivirals against hepatitis C virus-Results from a pilot studyEuropean Journal of Clinical Investigation 2018; 48(12): e13024 doi: 10.1111/eci.13024
134
Jae Ho Choi, Seul Mi Kim, Gi Ho Lee, Sun Woo Jin, Hyun Sun Lee, Young Chul Chung, Hye Gwang Jeong. Platyconic Acid A, Platycodi Radix-Derived Saponin, Suppresses TGF-β1-Induced Activation of Hepatic Stellate Cells via Blocking SMAD and Activating the PPARγ Signaling PathwayCells 2019; 8(12): 1544 doi: 10.3390/cells8121544
135
Gisli Jenkins. Demystifying pulmonary fibrosisAmerican Journal of Physiology-Lung Cellular and Molecular Physiology 2020; 319(3): L554 doi: 10.1152/ajplung.00365.2020
136
Thierry Lefebvre, Léonie Petitclerc, Mélanie Hébert, Laurent Bilodeau, Giada Sebastiani, Damien Olivié, Zu‐Hua Gao, Marie‐Pierre Sylvestre, Guy Cloutier, Bich N. Nguyen, Guillaume Gilbert, An Tang. MRI cine‐tagging of cardiac‐induced motion for noninvasive staging of liver fibrosisJournal of Magnetic Resonance Imaging 2020; 51(5): 1570 doi: 10.1002/jmri.26935
137
Akash Chandra Das, Aidin Foroutan, Brian Qian, Nader Hosseini Naghavi, Kayvan Shabani, Parisa Shooshtari. Single-Cell Chromatin Accessibility Data Combined with GWAS Improves Detection of Relevant Cell Types in 59 Complex PhenotypesInternational Journal of Molecular Sciences 2022; 23(19): 11456 doi: 10.3390/ijms231911456